Yüklüyor......
Using the Immunophenotype to Predict Response to Biologic Drugs in Rheumatoid Arthritis
Tumour necrosis factor (TNF)-α is a key mediator of inflammation in rheumatoid arthritis, and its discovery led to the development of highly successful anti-TNF therapy. Subsequently, other biologic drugs targeting immune pathways, namely interleukin-6 blockade, B cell depletion, and T cell co-stimu...
Kaydedildi:
| Yayımlandı: | J Pers Med |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6963853/ https://ncbi.nlm.nih.gov/pubmed/31581724 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jpm9040046 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|